EyePoint Sues Ocular Over False Drug Claims

Lawsuit Alleges Misleading Statements

EyePoint Pharmaceuticals has initiated legal action against rival Ocular Therapeutix, filing a lawsuit that accuses the company of disseminating false or misleading information. The complaint centers on EyePoint's lead experimental eye drug, Duravyu.

The lawsuit was officially filed in the Middlesex County Superior Court for the Commonwealth of Massachusetts.

Overview of the Situation

Both companies are significant competitors in the race to develop advanced, longer-lasting treatments for severe retinal diseases. A primary focus is wet age-related macular degeneration, or wet AMD, a leading cause of vision loss among older adults.

EyePoint alleges that Ocular Therapeutix made statements that misrepresented both the company and the clinical results of Duravyu, accusing them of defamation, commercial disparagement, and violations of Massachusetts consumer protection law.

Impact on the Market

EyePoint is seeking a court order to halt the statements, a public retraction, and monetary damages. This legal conflict could influence investor perception and stock performance for both firms as they navigate late-stage trials.

An Ocular spokesperson stated, “We’re confident in our statements and look forward to responding in the course of the legal process.”

Summary

This lawsuit underscores the intense competition within the biopharmaceutical sector, specifically in the ophthalmic drug market. The outcome will be closely monitored by investors, as it could affect the market positions of EyePoint's Duravyu and Ocular's competing drug, Axpaxli.

FAQ

Q: Why is EyePoint suing Ocular Therapeutix?
A: EyePoint alleges that Ocular Therapeutix spread false or misleading information about its company and its experimental eye drug, Duravyu.

Q: What market are these companies competing in?
A: They are competitors in developing treatments for serious retinal diseases, including wet age-related macular degeneration (wet AMD).

Source: Investing.com